Washington, D.C., partner Mercedes Meyer was quoted in a World Intellectual Property Review (WIPR) article titled, “13 from 2013: Cases of the Year.”

The article examined the implications of the 13 most interesting high-profile intellectual property disputes this year.  Mercedes commented on the Supreme Court case that held unanimously that isolated human DNA is patent-ineligible, wiping out some of Myriad Genetics’ claims.  But the court said, in some circumstances, composition claims for complementary DNA (cDNA), which is synthesized from messenger RNA, can be patented.

Mercedes said, “The case creates another gaping hole for what is patent eligible in the area of biotechnology compositions.  Despite the court’s attempt to restrict its decision to cDNA, it will likely impact additional technology areas.”

To read the full article, please click here.